Suchergebnisse - (Person:"Fajgenbaum, David C")

PubPharm (38)

1

Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman disease

enthalten in: The Journal of clinical investigation | 2019

von Fajgenbaum, D. | Langan, R. | Japp, A. | +20

CommentIn: J Clin Invest. 2019 Oct 1;129(10):4086-4088. - PMID 31524635

2

Quantitative analysis of a rare disease network's international contact database and E-repository provides insights into biobanking in the electronic consent era

enthalten in: Orphanet journal of rare diseases | 2019

von Suarez, A. | Reilly, C. | Fajgenbaum, D.

3

Quantitative analysis of a rare disease network’s international contact database and E-repository provides insights into biobanking in the electronic consent era

enthalten in: Orphanet journal of rare diseases | 2019

von Suarez, A. | Reilly, C. | Fajgenbaum, D.

4

Letter to the editor regarding 'Non-cirrhotic portal hypertension associated with multicentric Castleman's disease : a case report'

enthalten in: Acta oncologica (Stockholm, Sweden) | 2019

von Kobrin, D. | Pinto, A. | Parente, S. | +4

5

Phase 2 study using oral thalidomide-cyclophosphamide-prednisone for idiopathic multicentric Castleman disease

enthalten in: Blood | 2019

von Zhang, L. | Zhao, A. | Duan, M. | +7

CommentIn: Blood. 2019 Apr 18;133(16):1697-1698. - PMID 31000513

6

The Collaborative Network Approach : a model for advancing patient-centric research for Castleman disease and other rare diseases

enthalten in: Emerging topics in life sciences | 2019

von Zuccato, M. | Shilling, D. | Fajgenbaum, D.

7

Predictors of response to anti-IL6 monoclonal antibody therapy (siltuximab) in idiopathic multicentric Castleman disease : secondary analyses of phase II clinical trial data

enthalten in: British journal of haematology | 2019

von Morra, D. | Pierson, S. | Shilling, D. | +6

8

Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease

enthalten in: PloS one | 2019

von Nabel, C. | Sameroff, S. | Shilling, D. | +13

9

Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease

enthalten in: Hematology. American Society of Hematology. Education Program | 2018

von Fajgenbaum, D.

10

Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease

enthalten in: Blood | 2018

von Fajgenbaum, D.